{"id":168500,"date":"2025-05-27T06:30:11","date_gmt":"2025-05-27T10:30:11","guid":{"rendered":"https:\/\/44.250.171.167\/?p=168500"},"modified":"2025-05-27T06:30:11","modified_gmt":"2025-05-27T10:30:11","slug":"biocon-ltd-q4fy25-106-rise-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/biocon-ltd-q4fy25-106-rise-in-profits\/","title":{"rendered":"Biocon Ltd Q4FY25; 106% rise in Profits"},"content":{"rendered":"<p>Biocon is engaged in the business of manufacture of biotechnology products and research services.(Source : 202003-01 Annual Report Page No:195)<\/p>\n<p>Financial Results:<\/p>\n<p>Biocon Ltd reported Revenues for Q4FY25 of \u20b94,417.00 Crores up from \u20b93,917.00 Crore year on year, a rise of 12.76%.<\/p>\n<p>Total Expenses for Q4FY25 of \u20b93,987.00 Crores up from \u20b93,638.00 Crores year on year, a rise of 9.59%.<\/p>\n<p>Consolidated Net Profit of \u20b9459.00 Crores up 105.83% from \u20b9223.00 Crores in the same quarter of the previous year.<\/p>\n<p>The Earnings per Share is \u20b92.87, up 153.98% from \u20b91.13 in the same quarter of the previous year.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-168501\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/L-12.png\" alt=\"\" width=\"1489\" height=\"1817\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/L-12.png 1489w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/L-12-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/L-12-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/L-12-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/L-12-1259x1536.png 1259w\" sizes=\"auto, (max-width: 1489px) 100vw, 1489px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Biocon is engaged in the business of manufacture of biotechnology products and research services.(Source : 202003-01 Annual Report Page No:195) Financial Results: Biocon Ltd reported Revenues for Q4FY25 of \u20b94,417.00 Crores up from \u20b93,917.00 Crore year on year, a rise of 12.76%. Total Expenses for Q4FY25 of \u20b93,987.00 Crores up from \u20b93,638.00 Crores year on [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":168501,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[3187],"class_list":["post-168500","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","tag-biotechnology"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/L-12.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":165678,"url":"https:\/\/alphastreet.com\/india\/biocon-ltd-q2fy25-84-fall-in-profits\/","url_meta":{"origin":168500,"position":0},"title":"Biocon Ltd Q2FY25; 84% fall in Profits","author":"Divyansh_Kasana","date":"November 18, 2024","format":false,"excerpt":"Biocon is engaged in the business of manufacture of biotechnology products and research services.(Source : 202003-01 Annual Report Page No:195) Financial Results: Biocon Ltd reported Revenues for Q2FY25 of \u20b93,590.00 Crores up from \u20b93,462.00 Crore year on year, a rise of 3.7%. Total Expenses for Q2FY25 of \u20b93,551.00 Crores up\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/DI.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/DI.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/DI.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/DI.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/DI.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/DI.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":168082,"url":"https:\/\/alphastreet.com\/india\/syngene-international-ltd-q4fy25-3-fall-in-profits\/","url_meta":{"origin":168500,"position":1},"title":"Syngene International Ltd Q4FY25; 3% fall in Profits","author":"Chirag Gupta","date":"April 24, 2025","format":false,"excerpt":"Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO) which expanded later to be an integrated service provider offering end-to-end drug discovery, development, and manufacturing services on a single platform (CRAMS). Total research & manufacturing infrastructure for the company is spread across 1.9 million\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/1-14.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/1-14.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/1-14.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/1-14.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/1-14.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/04\/1-14.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":157327,"url":"https:\/\/alphastreet.com\/india\/biocon-ltd-q2fy24-111-rise-in-profits\/","url_meta":{"origin":168500,"position":2},"title":"Biocon Ltd Q2FY24; 111% rise in Profits","author":"Divyansh_Kasana","date":"December 14, 2023","format":false,"excerpt":"Biocon is engaged in the business of manufacture of biotechnology products and research services. Financial Results: Biocon Ltd reported Revenues for Q2FY24 of \u20b93,462.00 Crores up from \u20b92,320.00 Crore year on year, a rise of 49.22%. Total Expenses for Q2FY24 of \u20b93,382.00 Crores up from \u20b92,138.00 Crores year on year,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-106.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-106.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-106.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-106.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-106.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-106.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":164138,"url":"https:\/\/alphastreet.com\/india\/biocon-ltd-q1fy25-479-rise-in-profits\/","url_meta":{"origin":168500,"position":3},"title":"Biocon Ltd Q1FY25; 479% rise in Profits","author":"Divyansh_Kasana","date":"August 28, 2024","format":false,"excerpt":"Biocon is engaged in the business of manufacture of biotechnology products and research services. Financial Results: Biocon Ltd reported Revenues for Q1FY25 of \u20b93,433.00 Crores up from \u20b93,423.00 Crore year on year, a rise of 0.29%. Total Expenses for Q1FY25 of \u20b93,453.00 Crores up from \u20b93,332.00 Crores year on year,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-187.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-187.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-187.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-187.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-187.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-187.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":161804,"url":"https:\/\/alphastreet.com\/india\/biocon-ltd-q4fy24-46-fall-in-profits\/","url_meta":{"origin":168500,"position":4},"title":"Biocon Ltd Q4FY24; 46% fall in Profits","author":"Divyansh_Kasana","date":"June 3, 2024","format":false,"excerpt":"Biocon is engaged in the business of manufacture of biotechnology products and research services.(Source : 202003-01 Annual Report Page No:195) Financial Results: Biocon Ltd reported Revenues for Q4FY24 of \u20b93,917.00 Crores up from \u20b93,774.00 Crore year on year, a rise of 3.79%. Total Expenses for Q4FY24 of \u20b93,638.00 Crores up\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-23.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-23.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-23.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-23.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-23.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-23.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":152755,"url":"https:\/\/alphastreet.com\/india\/biocon-ltd-q1fy24-11-fall-in-profits\/","url_meta":{"origin":168500,"position":5},"title":"Biocon Ltd Q1FY24; 11% fall in Profits","author":"Divyansh_Kasana","date":"August 11, 2023","format":false,"excerpt":"Biocon is engaged in the business of manufacture of biotechnology products and research services.(Source : 202003-01 Annual Report Page No:195) Financial Results: Biocon Ltd reported Revenues for Q1FY24 of \u20b93,423.00 Crores up from \u20b92,140.00 Crore year on year, a rise of 59.95%. Total Expenses for Q1FY24 of \u20b93,332.00 Crores up\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-694.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-694.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-694.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-694.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-694.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-694.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/168500","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=168500"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/168500\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/168501"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=168500"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=168500"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=168500"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}